Hemanext

Hemanext is a privately held medical technology company based in Massachusetts, dedicated to improving the quality, safety, efficacy, and cost of transfusion therapy. The company’s research and development efforts focus on studying hypoxia-stored red blood cells (RBCs). Hemanext aims to significantly enhance the quality of stored RBCs by limiting oxygen and carbon dioxide levels in the storage environment. Our corporate mission is to support the transfusion medicine community in saving lives and improving patient outcomes. Our unique focus is on innovations that drive meaningful advancements in transfusion therapy.